8-K: HeartCore Pivots to IPO Consulting, Reports Q3 2025 Financials

HeartCore Enterprises, Inc. announced its Q3 2025 financial results and a strategic pivot to focus entirely on its Go IPO consulting business after divesting its software subsidiary.

Summary

• Divested software business subsidiary, HeartCore Co., Ltd. (HeartCore Japan), in an all-cash transaction.
• Made a full pivot into the Go IPO business, focusing on IPO consulting services.
• Implemented meaningful expense reductions to lower operating costs going forward.
• Authorized and paid a one-time distribution payment to stockholders using a portion of the divestiture proceeds.
• Continuing to assess strategic alternatives to divest subsidiary, Sigmaways.
• Signed 16th Go IPO client.
• One Go IPO client, rYojbaba Co., Ltd., successfully began trading on the Nasdaq Stock Market.
• Anticipates another client will commence trading soon.
• In discussions with several prospective Korean clients following a Go IPO Korea seminar, with hopes to materialize them in the near future.
• Demand from Japan remains strong, and the company expects to engage additional potential clients in the next few months.
• Third Quarter 2025 Revenues were $3.0 million, compared to $16.2 million in the same period last year, primarily due to a $13 million signature warrant revenue in the prior period.
• Third Quarter 2025 Gross profit was $1.5 million, compared to $14.0 million in the same period last year.
• Third Quarter 2025 Operating expenses decreased to $1.5 million, compared to $1.7 million in the same period last year, due to cost-cutting.
• Third Quarter 2025 Net income was $0.4 million, compared to a net income of $10.8 million in the same period last year.
• Third Quarter 2025 Adjusted EBITDA was $0.5 million, compared to $12.0 million in the same period last year.
• Nine Months 2025 Revenues were $7.1 million, compared to $21.3 million in the same period last year, primarily due to a $13 million signature warrant revenue in the prior period.
• Nine Months 2025 Gross profit was $2.6 million, compared to $15.1 million in the same period last year.
• Nine Months 2025 Operating expenses decreased to $4.5 million, compared to $5.5 million in the same period last year.
• Nine Months 2025 Net loss was $1.7 million, compared to a net income of $7.1 million in the same period last year.
• Nine Months 2025 Adjusted EBITDA was $(0.6) million, compared to $10.4 million in the same period last year.
• Cash and cash equivalents were $1.5 million as of September 30, 2025, compared to $2.0 million on December 31, 2024.
• On a pro forma basis, as of November 18, 2025, the company has approximately $2.5 million of cash and cash equivalents, after the one-time payment to stockholders.

Sentiment

Score: 5

Explanation: The strategic pivot and expense reductions are positive, indicating a clear direction and cost control. The strong pipeline for Go IPO clients is also encouraging. However, the significant year-over-year decline in financial metrics (revenue, profit, EBITDA) due to the absence of a large prior-period deal warrants caution, even with the explanation. The pro forma cash position is an improvement. It's a mixed bag of strategic positives and financial negatives (though explained).

Positives

• Successfully divested software business subsidiary, HeartCore Japan, in an all-cash transaction.
• Made a strategic and transformative full pivot into the more profitable Go IPO business.
• Implemented meaningful expense reductions to lower operating costs going forward.
• Authorized and paid a one-time distribution payment to stockholders.
• Signed its 16th Go IPO client.
• One Go IPO client, rYojbaba Co., Ltd., successfully began trading on the Nasdaq Stock Market.
• Anticipates another client will commence trading soon, indicating continued client success.
• Strong pipeline with discussions ongoing with prospective Korean clients and strong demand from Japan.
• Pro forma cash and cash equivalents increased to approximately $2.5 million as of November 18, 2025, after the divestiture and distribution.

Negatives

• Third Quarter 2025 Revenues significantly decreased to $3.0 million from $16.2 million in Q3 2024.
• Third Quarter 2025 Gross profit substantially decreased to $1.5 million from $14.0 million in Q3 2024.
• Third Quarter 2025 Net income fell to $0.4 million from $10.8 million in Q3 2024.
• Third Quarter 2025 Adjusted EBITDA dropped to $0.5 million from $12.0 million in Q3 2024.
• Nine Months 2025 Revenues decreased to $7.1 million from $21.3 million in 9M 2024.
• Nine Months 2025 Gross profit decreased to $2.6 million from $15.1 million in 9M 2024.
• Nine Months 2025 resulted in a Net loss of $1.7 million, compared to a net income of $7.1 million in 9M 2024.
• Nine Months 2025 Adjusted EBITDA was negative $(0.6) million, compared to $10.4 million in 9M 2024.
• The significant revenue and profit decreases are primarily attributed to the absence of a $13 million signature warrant revenue from a large Go IPO deal in the prior period.

Risks

• Forward-looking statements involve known and unknown uncertainties and other factors which could materially affect actual results, levels of activity, performance, or achievements.
• The success of the strategic pivot relies on the continued demand for U.S. exchange listings from Japanese and Korean companies and the company's ability to secure and successfully guide these clients.
• Uncertainty exists regarding the assessment of strategic alternatives to divest the subsidiary, Sigmaways.

Future Outlook

The company anticipates another Go IPO client will commence trading soon. Following a Go IPO Korea seminar, discussions are ongoing with several prospective Korean clients, with hopes to materialize them in the near future. Demand from Japan remains strong, and the company expects to engage additional potential clients in the next few months. The full transition to the Go IPO business allows for dedicated resources to its growth and continued expansion in Japan and Korea.

Management Comments

• "This past month, we made the strategic and transformative decision to divest our software business subsidiary, HeartCore Japan, in an all-cash transaction, effectively making a full pivot into our Go IPO business." Sumitaka Kanno, CEO.
• "We believe this move positions HeartCore for long-term, sustainable success by sharpening our focus on a more profitable business in Go IPO." Sumitaka Kanno, CEO.
• "In parallel with this transaction, we also implemented meaningful expense reductions that will help lower operating costs going forward." Sumitaka Kanno, CEO.
• "A portion of the divestiture proceeds was used towards the one-time distribution payment, which was paid out yesterday." Sumitaka Kanno, CEO.
• "We are also continuing to assess all strategic alternatives to divest our subsidiary, Sigmaways. We believe this move will support our bottom-line performance going forward and further accelerate our shift towards the IPO consulting space." Sumitaka Kanno, CEO.
• "In recent months, we signed our 16th Go IPO client, saw one client successfully begin trading, and anticipate another will commence trading soon." Sumitaka Kanno, CEO.
• "Additionally, following our Go IPO Korea seminar, we have been in discussion with several prospective Korean clients which we hope to materialize in the near future. Demand from Japan also remains strong, and we believe we are on the precipice of engaging additional potential clients in the next few months." Sumitaka Kanno, CEO.
• "This full transition into our Go IPO business now allows us to dedicate more time and resources to its growth, and with a strong pipeline, we look forward to continued expansion of our IPO consulting business in Japan and Korea." Sumitaka Kanno, CEO.

Industry Context

HeartCore is pivoting to focus solely on IPO consulting services, specifically guiding Japanese growth companies to U.S. exchange listings. This move positions them as a specialized player in the niche market of cross-border IPO facilitation, particularly for Asian companies targeting U.S. capital markets. The success hinges on the continued demand for U.S. listings from Japanese and Korean companies and HeartCore's ability to secure and successfully guide these clients.

Comparison to Industry Standards

• The filing does not provide specific comparable companies or projects to benchmark against within the IPO consulting industry.
• The 'Go IPO' business model, which involves comprehensive consulting for U.S. exchange listings, is a specialized service. Key success metrics for such services typically include the number of successful listings, client acquisition rate, and revenue per client.
• The significant year-over-year revenue decline in Q3 and 9M 2025 is attributed to the absence of a large warrant revenue from a prior period, making direct financial comparisons challenging without understanding the typical revenue recognition patterns for such consulting services.
• The company's strategic focus on Japan and Korea suggests a regional specialization, which can be a competitive advantage in the global market for IPO consulting services.

Related Party Transactions

• Cost of revenues includes transactions with a related party of $61,078 for Q3 2025 and $117,601 for 9M 2025.
• General and administrative expenses include transactions with a related party of nil for Q3 2025 and $29,048 for 9M 2025.
• Accounts payable and accrued expenses related party: $25,507 as of September 30, 2025 (compared to $47,199 on December 31, 2024).
• Short-term debt related party: $70,900 as of September 30, 2025 (compared to $75,000 on December 31, 2024).
• Repayment of related party debt: $(4,100) for the nine months ended September 30, 2025.

Stakeholder Impact

• Shareholders: Received a one-time distribution payment. The strategic pivot aims for long-term, sustainable success and a more profitable business, potentially benefiting shareholders in the future, though current financial performance is significantly down year-over-year.
• Employees: Expense reductions were implemented, which could imply workforce adjustments, though not explicitly stated. The pivot to a focused business might lead to a more streamlined organization.
• Customers (Go IPO clients): The company is dedicating more time and resources to the Go IPO business, potentially improving service quality and client success rates.
• Creditors: The company's cash position improved pro forma after the divestiture, which could be positive for liquidity.

Next Steps

• Continue to assess strategic alternatives to divest subsidiary, Sigmaways.
• Materialize discussions with prospective Korean clients into contracts.
• Engage additional potential clients in Japan.
• Continued expansion of the IPO consulting business in Japan and Korea.
• Another Go IPO client is anticipated to commence trading soon.

Key Dates

Recommendation

The company is undergoing a significant strategic transformation by divesting its software business and focusing entirely on the Go IPO consulting segment. While the financial results for Q3 and 9M 2025 show a substantial year-over-year decline, this is largely attributed to a non-recurring large warrant revenue in the prior period, rather than a fundamental deterioration of the core Go IPO business. The pivot to a more profitable, focused business, coupled with expense reductions and a strong pipeline of new clients, presents a clear path for future growth. The one-time distribution to shareholders and improved pro forma cash position are also positive. However, the success of this pivot is still unfolding, and the company needs to demonstrate consistent revenue generation from its Go IPO services to offset the past reliance on large, potentially irregular, deals. Investors should hold to observe the execution of this new strategy and the realization of its anticipated profitability and growth.

Keywords

IPO consulting, Go IPO, Nasdaq listing, financial results, Q3 2025, divestiture, HeartCore Japan, corporate strategy, expense reduction, Japan, Korea